Ramipril 5 mg Capsules

What this means

The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.

Class 2 recall · DMRC- 38717889

Batches (expiry): GR164099 (10/2026)

Background: Crescent Pharma Limited is recalling one batch of Ramipril 5 mg Capsules as a precautionary measure due to a potential error at the manufacturing site. Crescent Pharma Limited has received one complaint to date, where it has been identified that a pack of Ramipril 5 mg Capsules (Batch Number GR164099) contains blister strips of Amlodipine 5 mg Tablets inside the sealed carton. Both products were manufactured at the same manufacturing site and the error appears to have occurred during secondary packaging of the blister strips into the cartons. Please note this is a Class 2 Patient, Pharmacy and Wholesaler level recall. Advice for Healthcare Professionals: Stop supplying the impacted batch of Ramipril 5 mg Capsules immediately. Quarantine all remaining stock and return it to your supplier using your approved process.